| Antiretroviral Therapy for HIV Infection |
1 |
1 |
| HIV Infection |
0 |
0.99 |
| Clinical Research |
0 |
0.47 |
| Drug Abuse |
0 |
0.34 |
| Substance Abuse |
0 |
0.34 |
| Abuse |
0 |
0.32 |
| CD4 |
0 |
0.32 |
| Epidemic |
0 |
0.32 |
| Mental Illness |
0 |
0.32 |
| Quality of Life |
0 |
0.32 |
| California |
0 |
0.16 |
| Cellulitis |
0 |
0.16 |
| Immunology |
0 |
0.16 |
| Medical Innovations |
0 |
0.16 |
| North Carolina |
0 |
0.16 |
| Opportunistic Infection |
0 |
0.16 |
| Plasma |
0 |
0.16 |
| Psychosocial |
0 |
0.16 |
| Salary and Compensation |
0 |
0.16 |
| Healthcare and Medical Technology |
0 |
0.14 |
| Addiction |
0 |
0.1 |
| Acute Bacterial Skin Infections |
0 |
0.04 |
| Neuroendocrine Tumor |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |
| Skin and Soft Tissue Infection |
0 |
0.04 |